CMMB

Chemomab Therapeutics

1.74 USD
+0.00
0.00%
At close Nov 14, 4:00 PM EST
After hours
1.72
-0.02
1.15%
1 day
0.00%
5 days
18.37%
1 month
45.00%
3 months
67.31%
6 months
97.73%
Year to date
223.54%
1 year
185.25%
5 years
-97.05%
10 years
-97.05%
0
Funds holding %
of 6,759 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

18% more capital invested

Capital invested by funds: $2.08M [Q1] → $2.45M (+$370K) [Q2]

7% more funds holding

Funds holding: 14 [Q1] → 15 (+1) [Q2]

0% more ownership

Funds ownership: 0.94% [Q1] → 0.94% (+0%) [Q2]

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Research analyst outlook

We haven’t received any recent analyst ratings for CMMB.

Financial journalist opinion

Charts implemented using Lightweight Charts™